Pancreatic cancer remains difficult to treat, and is responsible for around 8 percent of all cancer deaths.It also has one of ...

Pancreatic cancer has a low survival rate and is usually found too late — this new test may help change that Researchers have ...

The FDA granted RMAT designation to nogapendekin alfa and CAR-NK for reversing lymphopenia in patients with cancer, with ...

A rapid nanosensor assay that measures serum protease cleavage of a target-probe nanosensor can identify pancreatic ductal ...

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...

A new assay rapidly detected pancreatic ductal adenocarcinoma and differentiated it from noncancer pancreatic diseases by ...

A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.

ImmunityBio shares advanced 17% to $3.34 after the company said the Food and Drug Administration awarded a regenerative medicine advanced therapy designation for Anktiva and CAR-NK for the reversal of ...

Thanks to decades of sustained, predictable federal investments and increases in pancreatic cancer research, the research ...

The Republican who was Illinois governor throughout the 1990s said he was diagnosed in mid-January and has undergone three ...

All Babbo Italian Eatery profits on Feb. 26 benefit pancreatic cancer research. It's part of the annual Baseball for Babbo ...